Another Piece of Evidence for Early Administration of Biologics in Children with Crohn's Disease Who Start as an Inflammatory Phenotype

Gut Liver. 2021 Nov 15;15(6):791-792. doi: 10.5009/gnl210508.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Biological Products*
  • Child
  • Crohn Disease* / drug therapy
  • Humans
  • Infliximab
  • Phenotype

Substances

  • Antibodies, Monoclonal
  • Biological Products
  • Infliximab